Sie befinden sich hier


Publications with MCTN Affiliation 2022

  1. Quantification of tissue sodium concentration in the ischemic stroke: A comparison between external and internal references for (23)Na MRI.
    Adlung A, Licht C, Reichert S, Ozdemir S, Mohamed SA, Samartzi M, Fatar M, Gass A, Prost EN, and Schad LR. J Neurosci Methods. 2022. 382:109721.
    DOI: 10.1016/j.jneumeth.2022.109721. 
    Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus.
  2. Agelopoulos K, Renkhold L, Wiegmann H, Dugas M, Suer A, Zeidler C, Schmelz M, Pereira MP, and Stander S. J Invest Dermatol. 2022.
    DOI: 10.1016/j.jid.2022.08.042. 
  3. Simultaneous EEG/MEG yields complementary information of nociceptive evoked responses.
    Ahmed Mahmutoglu M, Rupp A, and Baumgartner U. Clin Neurophysiol. 2022. 143:21-35.
    DOI: 10.1016/j.clinph.2022.08.005.
  4. [New aspects in neurointensive and emergency medicine: the most important studies in a review and overview].
    Alonso A, Kollmar R, and Dimitriadis K. Nervenarzt. 2022.
    DOI: 10.1007/s00115-022-01285-3. 
  5. The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective.
    Baldassari LE, Wattjes MP, Cortese ICM, Gass A, Metz I, Yousry T, Reich DS, and Richert N. Brain. 2022. 145(2):426-440.
    DOI: 10.1093/brain/awab419.
  6. Genetic lesions of the noradrenergic system trigger induction of oxidative stress and inflammation in the ventral midbrain.
    Barut J, Rafa-Zablocka K, Jurga AM, Baginska M, Nalepa I, Parlato R, and Kreiner G. Neurochem Int. 2022. 155:105302.
    DOI: 10.1016/j.neuint.2022.105302. 
  7. Bradykinin-Induced Sensitization of Transient Receptor Potential Channel Melastatin 3 Calcium Responses in Mouse Nociceptive Neurons.
    Behrendt M, Solinski HJ, Schmelz M, and Carr R. Front Cell Neurosci. 2022. 16:843225.
    DOI: 10.3389/fncel.2022.843225. 
  8. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
    Blankestijn M, Bloks VW, Struik D, Huijkman N, Kloosterhuis N, Wolters JC, Wanders RJA, Vaz FM, Islinger M, Kuipers F, van de Sluis B, Groen AK, Verkade HJ, and Jonker JW. Sci Rep. 2022. 12(1):2512.
    DOI: 10.1038/s41598-022-06479-y. 
  9. FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees.
    Brenner D, Muller K, Lattante S, Yilmaz R, Knehr A, Freischmidt A, Ludolph AC, Andersen PM, and Weishaupt JH. Neurogenetics. 2022. 23(1):59-65.
    DOI: 10.1007/s10048-021-00671-4.
  10. BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Brewer RC, Ramadoss NS, Lahey LJ, Jahanbani S, Robinson WH, and Lanz TV. Nat Immunol. 2022. 23(1):33-39.
    DOI: 10.1038/s41590-021-01088-9. 
  11. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C, Aeschlimann M, Barta C, Begeman AHA, Backer A, Crunelle CL, Daigre C, De Fuentes-Merillas L, Demetrovics Z, Dom G, Lopez LG, Icick R, Johnson B, Joostens P, Kapitany-Foveny M, Karsinti E, Kiefer F, Konstenius M, Levin FR, Luderer M, Markus W, Matthys F, Moggi F, Palma-Alvarez RF, Paraskevopoulou M, Ramos-Quiroga JA, Schellekens A, Soravia LM, Therribout N, Thomas A, van de Glind G, van Kernebeek MW, Vollstadt-Klein S, Vorspan F, van den Brink W, and Franck J. BMC Psychiatry. 2022. 22(1):625.
    DOI: 10.1186/s12888-022-04259-6.
  12. Increased NF-L levels in the TDP-43(G298S) ALS mouse model resemble NF-L levels in ALS patients.
    Buck E, Oeckl P, Grozdanov V, Bopp V, Kuhlwein JK, Ruf WP, Wiesner D, Roselli F, Weishaupt JH, Ludolph AC, Otto M, and Danzer KM. Acta Neuropathol. 2022. 144(1):161-164.
    DOI: 10.1007/s00401-022-02436-1. 
  13. Clinical and Translational Advances in Glioma Immunotherapy.
    Bunse L, Bunse T, Kramer C, Chih YC, and Platten M. Neurotherapeutics. 2022. 19(6):1799-1817.
    DOI: 10.1007/s13311-022-01313-9. 
  14. How mutant isocitrate dehydrogenase orchestrates immune cells.
    Bunse L and Platten M. Neuro Oncol. 2022. 24(2):210-212.
    DOI: 10.1093/neuonc/noab266. 
  15. AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
    Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, Misch M, Tabatabai G, Glas M, Schnell O, Gempt J, Denk M, Reifenberger G, Bendszus M, Wuchter P, Steinbach JP, Wick W, and Platten M. Neurol Res Pract. 2022. 4(1):20.
    DOI: 10.1186/s42466-022-00184-x. 
  16. Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV.
    Bunse L, Sommerer C, Tan CL, Korell F, Schmitt A, Huckelhoven-Krauss A, Neuber B, Mertens T, Platten M, Green EW, Zeier M, and Schmitt M. Int J Mol Sci. 2022. 23(3).
    DOI: 10.3390/ijms23031029. 
  17. Cerebral processing of sharp mechanical pain measured with arterial spin labeling.
    Cardinale V, Demirakca T, Gradinger T, Sack M, Ruf M, Kleindienst N, Schmitz M, Schmahl C, Baumgartner U, and Ende G. Brain Behav. 2022. 12(1):e2442.
    DOI: 10.1002/brb3.2442.
  18. Fission Impossible (?)-New Insights into Disorders of Peroxisome Dynamics.
    Carmichael RE, Islinger M, and Schrader M. Cells. 2022. 11(12).
    DOI: 10.3390/cells11121922. 
  19. Altered resting-state functional connectivity of default mode network in brachioradial pruritus.
    Dehghan Nayyeri M, Missler M, Ritterbach R, Sundermann B, Wulms N, Suer A, Dugas M, Pereira MP, Stander S, Schmelz M, and Pfleiderer B. J Eur Acad Dermatol Venereol. 2022.
    DOI: 10.1111/jdv.18411. 
  20. Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC.
    Dimitriadis K, Meis J, Neugebauer H, Barlinn K, Neumann B, Gahn G, Lochner P, Knier B, Lindemann S, Suhs KW, Szabo K, Pfefferkorn T, Schirotzek I, Freilinger T, Burc B, Gunther A, Wittstock M, Schramm P, Reimann G, Godau J, Nagy G, Koenig FB, Essig F, Klinker H, Hartmann C, Schmidbauer ML, Steinberg T, Lefterova L, Klose C, Bosel J, and group Is. Crit Care. 2022. 26(1):217.
    DOI: 10.1186/s13054-022-04080-3. 
  21. Deoxy-sphingolipids, oxidative stress, and vitamin C correlate with qualitative and quantitative patterns of small fiber dysfunction and degeneration.
    Dohrn MF, Dumke C, Hornemann T, Nikolin S, Lampert A, Espenkott V, Vollert J, Ouwenbroek A, Zanella M, Schulz JB, Gess B, and Rolke R. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002580. 
  22. Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions.
    Eisele P, Wittayer M, Weber CE, Platten M, Schirmer L, and Gass A. Mult Scler. 2022:13524585221106338.
    DOI: 10.1177/13524585221106338.
  23. Site-Specific Considerations on Engineered T Cells for Malignant Gliomas.
    Elmadany N, Alhalabi OT, Platten M, and Bunse L. Biomedicines. 2022. 10(7).
    DOI: 10.3390/biomedicines10071738.
  24. Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
    Fastner C, Szabo K, Samartzi M, Kruska M, Akin I, Platten M, Baumann S, and Alonso A. PLoS One. 2022. 17(2):e0264122.
    DOI: 10.1371/journal.pone.0264122. 
  25. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.
    Friedrich M, Hahn M, Michel J, Sankowski R, Kilian M, Kehl N, Gunter M, Bunse T, Pusch S, von Deimling A, Wick W, Autenrieth SE, Prinz M, Platten M, and Bunse L. Neuro Oncol. 2022.
    DOI: 10.1093/neuonc/noac138. 
  26. Device-Controlled Microcondensation for Spatially Confined On-Tissue Digests in MALDI Imaging of N-Glycans.
    Fulop A, Marsching C, Barka F, Ucal Y, Pfander P, Opitz CA, Barka G, and Hopf C. Pharmaceuticals (Basel). 2022. 15(11).
    DOI: 10.3390/ph15111356.
  27. Neural cue reactivity is not stronger in male than in female patients with alcohol use disorder.
    Gerhardt S, Hoffmann S, Tan H, Gerchen MF, Kirsch P, Vollstadt-Klein S, Kiefer F, Bach P, and Lenz B. Front Behav Neurosci. 2022. 16:1039917.
    DOI: 10.3389/fnbeh.2022.1039917. 
  28. Association Between Functional and Structural Brain Connectivity of the Default Mode Network in Non-treatment Seeking Individuals With Alcohol Use Disorder.
    Gerhardt S, Karl D, Mann K, Kiefer F, and Vollstadt-Klein S. Alcohol Alcohol. 2022. 57(5):540-551.
    DOI: 10.1093/alcalc/agab079. 
  29. Association of sensory phenotype with quality of life, functionality, and emotional well-being in patients suffering from neuropathic pain.
    Gierthmuhlen J, Bohmer J, Attal N, Bouhassira D, Freynhagen R, Haanpaa M, Hansson P, Jensen TS, Kennedy J, Maier C, Rice ASC, Sachau J, Segerdahl M, Sindrup S, Tolle T, Treede RD, Ventzel L, Vollert J, and Baron R. Pain. 2022. 163(7):1378-1387.
    DOI: 10.1097/j.pain.0000000000002501.
  30. Pearls And Oy-Sters: Hemiballism and Orbitofrontal-Like Syndrome in a Patient With Unilateral Tuberothalamic Stroke.
    Grassl N, Ebert AD, Szabo K, Aghazadeh Y, Platten M, and Alonso A. Neurology. 2022.
    DOI: 10.1212/WNL.0000000000201066. 
  31. Simulation, Implementation and Measurement of Defined Sound Fields for Blood-Brain Barrier Opening in Rats.
    Grudzenski S, Heger S, de Jonge A, Schipp J, Dumont E, Larrat B, Schad L, Platten M, and Fatar M. Ultrasound Med Biol. 2022. 48(3):422-436.
    DOI: 10.1016/j.ultrasmedbio.2021.10.003. 
  32. The effects of nalmefene on the impulsive and reflective system in alcohol use disorder: A resting-state fMRI study.
    Grundinger N, Gerhardt S, Karl D, Mann K, Kiefer F, and Vollstadt-Klein S. Psychopharmacology (Berl). 2022. 239(8):2471-2489.
    DOI: 10.1007/s00213-022-06137-1. 
  33. Pain severity ratings in the 11th revision of the International Classification of Diseases: a versatile tool for rapid assessment.
    Hay G, Korwisi B, Rief W, Smith BH, Treede RD, and Barke A. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002640. 
  34. Dendritic axon origin enables information gating by perisomatic inhibition in pyramidal neurons.
    Hodapp A, Kaiser ME, Thome C, Ding L, Rozov A, Klumpp M, Stevens N, Stingl M, Sackmann T, Lehmann N, Draguhn A, Burgalossi A, Engelhardt M, and Both M. Science. 2022. 377(6613):1448-1452.
    DOI: 10.1126/science.abj1861. 
  35. Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article I): a systematic review and description of methods.
    Hohenschurz-Schmidt D, Draper-Rodi J, Vase L, Scott W, McGregor A, Soliman N, MacMillan A, Olivier A, Cherian CA, Corcoran D, Abbey H, Freigang S, Chan J, Phalip J, Norgaard Sorensen L, Delafin M, Baptista M, Medforth NR, Ruffini N, Skott Andresen S, Ytier S, Ali D, Hobday H, Santosa A, Vollert J, and Rice ASC. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002723.
  36. Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article II): a meta-analysis relating methods to trial results.
    Hohenschurz-Schmidt D, Draper-Rodi J, Vase L, Scott W, McGregor A, Soliman N, MacMillan A, Olivier A, Cherian CA, Corcoran D, Abbey H, Freigang S, Chan J, Phalip J, Sorensen LN, Delafin M, Baptista M, Medforth NR, Ruffini N, Andresen SS, Ytier S, Ali D, Hobday H, Ngurah Agung Adhiyoga Santosa AA, Vollert J, and Rice ASC. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002730. 
  37. Sex-Specific Differences in Pre-Stroke Characteristics Reveal Vulnerability of Elderly Women.
    Hoyer C, Schlenker J, Sandikci V, Ebert A, Wittayer M, Platten M, and Szabo K. J Pers Med. 2022. 12(3).
    DOI: 10.3390/jpm12030344.
  38. The current landscape of immunotherapy for pediatric brain tumors.
    Hwang EI, Sayour EJ, Flores CT, Grant G, Wechsler-Reya R, Hoang-Minh LB, Kieran MW, Salcido J, Prins RM, Figg JW, Platten M, Candelario KM, Hale PG, Blatt JE, Governale LS, Okada H, Mitchell DA, and Pollack IF. Nat Cancer. 2022. 3(1):11-24.
    DOI: 10.1038/s43018-021-00319-0.
  39. Temporal and spatial summation of laser heat stimuli in cultured nociceptive neurons of the rat.
    Jubileum E, Binzen U, Treede RD, and Greffrath W. Pflugers Arch. 2022.
    DOI: 10.1007/s00424-022-02728-1.
  40. Greater baseline pain inclusion criteria in clinical trials increase regression to the mean effect: a modelling study.
    Kamerman PR and Vollert J. Pain. 2022. 163(6):e748-e758.
    DOI: 10.1097/j.pain.0000000000002468. 
  41. Insights Into the Peroxisomal Protein Inventory of Zebrafish.
    Kamoshita M, Kumar R, Anteghini M, Kunze M, Islinger M, Martins Dos Santos V, and Schrader M. Front Physiol. 2022. 13:822509.
    DOI: 10.3389/fphys.2022.822509. 
  42. Insights Into the Peroxisomal Protein Inventory of Zebrafish.
    Kamoshita M, Kumar R, Anteghini M, Kunze M, Islinger M, Martins Dos Santos V, and Schrader M. Front Physiol. 2022. 13:822509.
    DOI: 10.3389/fphys.2022.822509.
  43. Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey.
    Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, Agkatsev S, Blau T, Maurer I, Kahlert U, Sagerer A, Berberich A, Heider S, Muther M, Bodensohn R, and Behling F. Neuro Oncol. 2022.
    DOI: 10.1093/neuonc/noac114. 
  44. A comparison of self-reported pain measures between sensory phenotypes in HIV-associated sensory neuropathy.
    Kemp HI, Vollert J, Davies NW, Moyle GJ, and Rice AS. J Pain. 2022.
    DOI: 10.1016/j.jpain.2022.09.005. 
  45. Diabetic neuropathy is a generalized phenomenon with impact on hand functional performance and quality of life.
    Kender Z, Groener JB, Jende JME, Kurz FT, Fleming T, Sulaj A, Schuh-Hofer S, Treede RD, Bendszus M, Szendroedi J, Nawroth PP, and Kopf S. Eur J Neurol. 2022.
    DOI: 10.1111/ene.15446. 
  46. T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.
    Kilian M, Friedrich M, Sanghvi K, Green E, Pusch S, Kawauchi D, Lower M, Sonner JK, Kramer C, Zaman J, Jung S, Breckwoldt MO, Willimsky G, Eichmuller SB, von Deimling A, Wick W, Sahm F, Platten M, and Bunse L. Clin Cancer Res. 2022. 28(2):378-389.
    DOI: 10.1158/1078-0432.CCR-21-1881.
  47. Single-dose ethanol intoxication causes acute and lasting neuronal changes in the brain.
    Knabbe J, Protzmann J, Schneider N, Berger M, Dannehl D, Wei S, Strahle C, Tegtmeier M, Jaiswal A, Zheng H, Kruger M, Rohr K, Spanagel R, Bilbao A, Engelhardt M, Scholz H, and Cambridge SB. Proc Natl Acad Sci U S A. 2022. 119(25):e2122477119.
    DOI: 10.1073/pnas.2122477119. 
  48. Chronic pain in the 11th Revision of the International Classification of Diseases : users' questions answered.
    Korwisi B, Barke A, Rief W, Treede RD, and Kleinstauber M. Pain. 2022. 163(9):1675-1687.
    DOI: 10.1097/j.pain.0000000000002551. 
  49. Reliability and clinical utility of the chronic pain classification in the 11th Revision of the International Classification of Diseases from a global perspective: results from India, Cuba, and New Zealand.
    Korwisi B, Garrido Suarez BB, Goswami S, Gunapati NR, Hay G, Hernandez Arteaga MA, Hill C, Jones D, Joshi M, Kleinstauber M, Lopez Mantecon AM, Nandi G, Papagari CSR, Rabi Martinez MDC, Sarkar B, Swain N, Templer P, Tulp M, White N, Treede RD, Rief W, and Barke A. Pain. 2022. 163(3):e453-e462.
    DOI: 10.1097/j.pain.0000000000002379.
  50. Reliability and clinical utility of the chronic pain classification in the 11th Revision of the International Classification of Diseases from a global perspective: results from India, Cuba, and New Zealand.
    Korwisi B, Suarez BBG, Goswami S, Gunapati NR, Hay G, Arteaga MAH, Hill C, Jones D, Joshi M, Kleinstauber M, Mantecon AML, Nandi G, Papagari CSR, Martinez MDR, Sarkar B, Swain N, Templer P, Tulp M, White N, Treede RD, Rief W, and Barke A. Pain. 2022. 163(3):E453-E462.
    DOI: 10.1097/j.pain.0000000000002379. 
  51. Coronary Artery Disease in Patients Presenting With Acute Ischemic Stroke or Transient Ischemic Attack and Elevated Troponin Levels.
    Kruska M, Kolb A, Fastner C, Mildenberger I, Hetjens S, Kittel M, Bail K, Behnes M, Akin I, Borggrefe M, Szabo K, and Baumann S. Front Neurol. 2021. 12:781553.
    DOI: 10.3389/fneur.2021.781553.
  52. Local hyperexcitability of C-nociceptors may predict responsiveness to topical lidocaine in neuropathic pain.
    Landmann G, Stockinger L, Gerber B, Benrath J, Schmelz M, and Rukwied R. PLoS One. 2022. 17(7):e0271327.
    DOI: 10.1371/journal.pone.0271327. 
  53. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.
    Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, Teegen B, Dunn JE, Lock CB, Kipp LB, Cotham VC, Ueberheide BM, Aftab BT, Anderson MS, DeRisi JL, Wilson MR, Bashford-Rogers RJM, Platten M, Garcia KC, Steinman L, and Robinson WH. Nature. 2022. 603(7900):321-327.
    DOI: 10.1038/s41586-022-04432-7. 
  54. Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101.
    Le Rhun E, Oppong FB, van den Bent M, Wick W, Brandes AA, Taphoorn MJ, Platten M, Idbaih A, Clement PM, Preusser M, Golfinopoulos V, Gorlia T, and Weller M. Eur J Cancer. 2022. 178:13-22.
    DOI: 10.1016/j.ejca.2022.10.006. 
  55. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
    Leone C, Di Stefano G, Di Pietro G, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Finnerup NB, Garcia-Larrea L, Li T, Goetz M, Mouraux A, Pelz B, Pogatzki-Zahn E, Schilder A, Schnetter E, Schubart K, Tracey I, Troconiz IF, Van Niel H, Hernandez JMV, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Phillips KG, Truini A, and Treede RD. Trials. 2022. 23(1):739.
    DOI: 10.1186/s13063-022-06431-5. 
  56. Pre-Synaptic GABAA in NaV1.8(+) Primary Afferents Is Required for the Development of Punctate but Not Dynamic Mechanical Allodynia following CFA Inflammation.
    Liu S, Bonalume V, Gao Q, Chen JT, Rohr K, Hu J, and Carr R. Cells. 2022. 11(15).
    DOI: 10.3390/cells11152390.
  57. AMAZONE: prevention of persistent pain after breast cancer treatment by online cognitive behavioral therapy-study protocol of a randomized controlled multicenter trial.
    Lukas A, Theunissen M, Boer DK, van Kuijk S, Van Noyen L, Magerl W, Mess W, Buhre W, and Peters M. Trials. 2022. 23(1):595.
    DOI: 10.1186/s13063-022-06549-6.
  58. Cold allodynia is correlated to paroxysmal and evoked mechanical pain in complex regional pain syndrome (CRPS).
    Lunden LK, Kleggetveit IP, Schmelz M, and Jorum E. Scand J Pain. 2022. 22(3):533-542.
    DOI: 10.1515/sjpain-2021-0208. 
  59. Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression.
    Manta CP, Leibing T, Friedrich M, Nolte H, Adrian M, Schledzewski K, Krzistetzko J, Kirkamm C, David Schmid C, Xi Y, Stojanovic A, Tonack S, de la Torre C, Hammad S, Offermanns S, Kruger M, Cerwenka A, Platten M, Goerdt S, and Geraud C. Circulation. 2022.
    DOI: 10.1161/CIRCULATIONAHA.121.058615. 
  60. Predictive genetic testing for Motor neuron disease: time for a guideline?
    McNeill A, Amador MD, Bekker H, Clarke A, Crook A, Cummings C, McEwen A, McDermott C, Quarrell O, Renieri A, Roggenbuck J, Salmon K, Volk A, Weishaupt J, and International Alliance of ALSMNDA. Eur J Hum Genet. 2022. 30(6):635-636.
    DOI: 10.1038/s41431-022-01093-y. 
  61. Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR-Cas9 screen.
    Mennuni M, Filograna R, Felser A, Bonekamp NA, Giavalisco P, Lytovchenko O, and Larsson NG. Embo Reports. 2022. 23(1).
    DOI: 10.15252/embr.202153054. 
  62. Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR-Cas9 screen.
    Mennuni M, Filograna R, Felser A, Bonekamp NA, Giavalisco P, Lytovchenko O, and Larsson NG. EMBO Rep. 2022. 23(1):e53054.
    DOI: 10.15252/embr.202153054. 
  63. Starting the engine of the powerhouse: mitochondrial transcription and beyond.
    Miranda M, Bonekamp NA, and Kuhl I. Biol Chem. 2022. 403(8-9):779-805.
    DOI: 10.1515/hsz-2021-0416. 
  64. Altered resting-state functional connectivity of default mode network in brachioradial pruritus.
    Nayyeri MD, Missler M, Ritterbach R, Sundermann B, Wulms N, Suer A, Dugas M, Pereira MP, Stander S, Schmelz M, and Pfleiderer B. Journal of the European Academy of Dermatology and Venereology. 2022.
    DOI: 10.1111/jdv.18411. 
  65. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
    Nochi Z, Pia H, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Fardo F, Genser B, Goetz M, Kostenko AV, Leone C, Li T, Mouraux A, Pelz B, Pogatzki-Zahn E, Schilder A, Schnetter E, Schubart K, Stouffs A, Tracey I, Troconiz IF, Truini A, Van Niel J, Vela JM, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Tankisi H, Finnerup NB, Phillips KG, and Treede RD. Trials. 2022. 23(1):163.
    DOI: 10.1186/s13063-022-06087-1. 
  66. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.
    Opie-Martin S, Iacoangeli A, Topp SD, Abel O, Mayl K, Mehta PR, Shatunov A, Fogh I, Bowles H, Limbachiya N, Spargo TP, Al-Khleifat A, Williams KL, Jockel-Balsarotti J, Bali T, Self W, Henden L, Nicholson GA, Ticozzi N, McKenna-Yasek D, Tang L, Shaw PJ, Chio A, Ludolph A, Weishaupt JH, Landers JE, Glass JD, Mora JS, Robberecht W, Damme PV, McLaughlin R, Hardiman O, van den Berg L, Veldink JH, Corcia P, Stevic Z, Siddique N, Silani V, Blair IP, Fan DS, Esselin F, de la Cruz E, Camu W, Basak NA, Siddique T, Miller T, Brown RH, Al-Chalabi A, and Shaw CE. Nat Commun. 2022. 13(1):6901.
    DOI: 10.1038/s41467-022-34620-y. 
  67. Mechanical Punctate Pain Thresholds in Patients With Migraine Across Different Migraine Phases: A Narrative Review.
    Pan LH, Treede RD, and Wang SJ. Front Neurol. 2021. 12:801437.
    DOI: 10.3389/fneur.2021.801437. 
  68. Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study.
    Pan LH, Wang YF, Ling YH, Lai KL, Chen SP, Chen WT, Treede RD, and Wang SJ. Cephalalgia. 2022. 42(9):899-909.
    DOI: 10.1177/03331024221080572. 
  69. ALS-linked KIF5A DeltaExon27 mutant causes neuronal toxicity through gain-of-function.
    Pant DC, Parameswaran J, Rao L, Loss I, Chilukuri G, Parlato R, Shi L, Glass JD, Bassell GJ, Koch P, Yilmaz R, Weishaupt JH, Gennerich A, and Jiang J. EMBO Rep. 2022. 23(8):e54234.
    DOI: 10.15252/embr.202154234. 
  70. Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's disease.
    Pepe G, Capocci L, Marracino F, Realini N, Lenzi P, Martinello K, Bovier TF, Bichell TJ, Scarselli P, Di Cicco C, Bowman AB, Digilio FA, Fucile S, Fornai F, Armirotti A, Parlato R, Di Pardo A, and Maglione V. Mol Ther. 2022.
    DOI: 10.1016/j.ymthe.2022.09.004.
  71. Mechanisms and therapeutic targets for neuropathic itch.
    Pereira MP, Schmelz M, and Stander S. Curr Opin Neurobiol. 2022. 75:102573.
    DOI: 10.1016/j.conb.2022.102573. 
  72. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.
    Ratliff M, Kim H, Qi H, Kim M, Ku B, Azorin DD, Hausmann D, Khajuria RK, Patel A, Maier E, Cousin L, Ogier A, Sahm F, Etminan N, Bunse L, Winkler F, El-Khoury V, Platten M, and Kwon YJ. Int J Mol Sci. 2022. 23(12).
    DOI: 10.3390/ijms23126572. 
  73. Consistency of the "central vein sign" in chronic multiple sclerosis lesions.
    Reichl M, Wittayer M, Weber CE, Platten M, Gass A, and Eisele P. Mult Scler Relat Disord. 2022. 58:103530.
    DOI: 10.1016/j.msard.2022.103530. 
  74. Does the Augmentation of Trauma Informed Hatha Yoga Increase the Effect of Dialectical Behavior Therapy for Substance Use Disorders on Psychopathological Strain of Patients with Borderline Personality Disorder and Comorbid Substance Use Disorder? Results of a Quasi-Experimental Study.
    Riegler A, Bumb JM, Wisch C, Schuster R, Reinhard I, Hoffmann S, Frischknecht U, Enning F, Schmahl C, Kiefer F, and Koopmann A. Eur Addict Res. 2022:1-8.
    DOI: 10.1159/000526670. 
  75. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Barkhof F, Schoonheim MM, Strijbis EM, Vrenken H, Gallo A, Bisecco A, Ciccarelli O, Yiannakas M, Rovira A, Sastre-Garriga J, Palace J, Matthews L, Gass A, Eisele P, Lukas C, Bellenberg B, Margoni M, Preziosa P, Filippi M, and Group MS. J Neurol Neurosurg Psychiatry. 2022.
    DOI: 10.1136/jnnp-2022-329854.
  76. Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cells.
    Ruf WP, Hannon E, Freischmidt A, Grozdanov V, Brenner D, Muller K, Knehr A, Gunther K, Dorst J, Ammerpohl O, Danzer KM, Mill J, Ludolph AC, and Weishaupt JH. Neurobiol Aging. 2022. 116:16-24.
    DOI: 10.1016/j.neurobiolaging.2022.04.003. 
  77. Symptom Severity and Health-Related Quality of Life in Patients with Atrial Fibrillation: Findings from the Observational ARENA Study.
    Sadlonova M, Senges J, Nagel J, Celano C, Klasen-Max C, Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleeman T, Schneider S, Hochadel M, Suselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, and Herrmann-Lingen C. J Clin Med. 2022. 11(4).
    DOI: 10.3390/jcm11041140. 
  78. Impaired semantic memory during acute transient global amnesia.
    Sandikci V, Ebert A, Hoyer C, Platten M, and Szabo K. J Neuropsychol. 2022. 16(1):149-160.
    DOI: 10.1111/jnp.12251.
  79. PEX11beta and FIS1 cooperate in peroxisome division independently of mitochondrial fission factor.
    Schrader TA, Carmichael RE, Islinger M, Costello JL, Hacker C, Bonekamp NA, Weishaupt JH, Andersen PM, and Schrader M. J Cell Sci. 2022. 135(13).
    DOI: 10.1242/jcs.259924.
  80. Persistent muscle hyperalgesia after adolescent stress is exacerbated by a mild-nociceptive input in adulthood and is associated with microglia activation.
    Singaravelu SK, Goitom AD, Graf AP, Moerz H, Schilder A, Hoheisel U, Spanagel R, and Treede RD. Sci Rep. 2022. 12(1):18324.
    DOI: 10.1038/s41598-022-21808-x. 
  81. Rat dorsal horn neurons primed by stress develop a long-lasting manifest sensitization after a short-lasting nociceptive low back input.
    Singaravelu SK, Hoheisel U, Mense S, and Treede RD. Pain Rep. 2021. 6(1):e904.
    DOI: 10.1097/PR9.0000000000000904. 
  82. Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
    Singh K, Batich KA, Wen PY, Tan AC, Bagley SJ, Lim M, Platten M, Colman H, Ashley DM, Chang SM, Rahman R, Galanis E, Mansouri A, Puduvalli VK, Reardon DA, Sahebjam S, Sampson JH, Simes J, Berry DA, Zadeh G, Cloughesy TF, Mehta MP, Piantadosi S, Weller M, Heimberger AB, and Khasraw M. Clin Cancer Res. 2022. 28(4):585-593.
  83. DOI: 10.1158/1078-0432.CCR-21-2681. 
  84. Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progression.
    Sonmez A, Mustafa R, Ryll ST, Tuorto F, Wacheul L, Ponti D, Litke C, Hering T, Kojer K, Koch J, Pitzer C, Kirsch J, Neueder A, Kreiner G, Lafontaine DLJ, Orth M, Liss B, and Parlato R. Cell Death Dis. 2021. 12(12):1139.
    DOI: 10.1038/s41419-021-04432-x. 
  85. Reduced structural connectivity of the amygdala is associated with childhood trauma in adult patients with alcohol use disorder.
    Soravia LM, Denier N, Moggi F, Grieder M, Federspiel A, Tschuemperlin RM, Batschelet HM, Vollstadt-Klein S, Wiest R, Stein M, and Bracht T. Addict Biol. 2022. 27(3):e13164.
    DOI: 10.1111/adb.13164. 
  86. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.
    Strohm L, Hu Z, Suk Y, Ruhmkorf A, Sternburg E, Gattringer V, Riemenschneider H, Berutti R, Graf E, Weishaupt JH, Brill MS, Harbauer AB, Dormann D, Dengjel J, Edbauer D, and Behrends C. Life Sci Alliance. 2022. 5(11).
    DOI: 10.26508/lsa.202101327. 
  87. Assessment of automated craving across substances and across cultures: stability-analysis of the Craving Automated Scale (CAS).
    Tan H, Nakovics H, Zeng H, Copello A, Akhtar S, Lee AM, Kiefer F, and Vollstadt-Klein S. J Addict Dis. 2022. 40(3):405-414.
    DOI: 10.1080/10550887.2021.2015053. 
  88. Chronic musculoskeletal pain: traps and pitfalls in classification and management of a major global disease burden.
    Treede RD. Pain Rep. 2022. 7(5):e1023.
    DOI: 10.1097/PR9.0000000000001023. 
  89. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis.
    Trobisch T, Zulji A, Stevens NA, Schwarz S, Wischnewski S, Ozturk M, Perales-Paton J, Haeussler M, Saez-Rodriguez J, Velmeshev D, and Schirmer L. Acta Neuropathol. 2022. 144(5):987-1003.
    DOI: 10.1007/s00401-022-02497-2. 
  90.  Vulnerability for alcohol use disorder after adverse childhood experiences (AUDACE): protocol for a longitudinal fMRI study assessing neuropsychobiological risk factors for relapse.
    Turkmen C, Machunze N, Tan H, Gerhardt S, Kiefer F, and Vollstadt-Klein S. BMJ Open. 2022. 12(6):e058645.
    DOI: 10.1136/bmjopen-2021-058645. 
  91. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
    Valsasina P, Gobbi C, Zecca C, Rovira A, Sastre-Garriga J, Kearney H, Yiannakas M, Matthews L, Palace J, Gallo A, Bisecco A, Gass A, Eisele P, Filippi M, Rocca MA, and Group MS. Mult Scler. 2022. 28(6):885-899.
    DOI: 10.1177/13524585211045545.
  92. Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development.
    van Niel J, Bloms-Funke P, Caspani O, Cendros JM, Garcia-Larrea L, Truini A, Tracey I, Chapman SC, Marco-Arino N, Troconiz IF, Phillips K, Finnerup NB, Mouraux A, and Treede RD. Int J Mol Sci. 2022. 23(15).
    DOI: 10.3390/ijms23158295. 
  93. Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex.
    Van Schoor E, Ospitalieri S, Moonen S, Tome SO, Ronisz A, Ok O, Weishaupt J, Ludolph AC, Van Damme P, Van Den Bosch L, and Thal DR. Acta Neuropathol. 2022. 144(3):393-411.
    DOI: 10.1007/s00401-022-02466-9. 
  94. Review of techniques useful for the assessment of sensory small fiber neuropathies: Report from an IFCN expert group.
    Verdugo RJ, Matamala JM, Inui K, Kakigi R, Valls-Sole J, Hansson P, Nilsen KB, Lombardi R, Lauria G, Petropoulos IN, Malik RA, Treede RD, Baumgartner U, Jara PA, and Campero M. Clin Neurophysiol. 2022. 136:13-38.
    DOI: 10.1016/j.clinph.2022.01.002.
  95. Dose-Dependent Pain and Pain Radiation after Chemical Stimulation of the Thoracolumbar Fascia and Multifidus Muscle: A Single-Blinded, Cross-Over Study Revealing a Higher Impact of Fascia Stimulation.
    Vogel S, Magerl W, Treede RD, and Schilder A. Life (Basel). 2022. 12(3).
    DOI: 10.3390/life12030340. 
  96. Sensory testing might not be perfect - but it is the best biomarker for pain phenotypes we have right now.
    Vollert J. Scand J Pain. 2022. 22(4):673-675.
    DOI: 10.1515/sjpain-2022-0092. 
  97. The EQIPD framework for rigor in the design, conduct, analysis and documentation of animal experiments.
    Vollert J, Macleod M, Dirnagl U, Kas MJ, Michel MC, Potschka H, Riedel G, Wever KE, Wurbel H, Steckler T, Consortium E, and Rice ASC. Nat Methods. 2022. 19(11):1334-1337.
    DOI: 10.1038/s41592-022-01615-y. 
  98. Conditioned pain modulation and offset analgesia: Influence of sex, sex hormone levels and menstrual cycle on the magnitude and retest reliability in healthy participants.
    Vollert J, Trewartha N, Kemkowski D, Cremer AF, Zahn PK, Segelcke D, and Pogatzki-Zahn EM. Eur J Pain. 2022.
    DOI: 10.1002/ejp.2014.
  99. Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.
    Vollert J, Wang R, Regis S, Yetman H, Lembo AJ, Kaptchuk TJ, Cheng V, Nee J, Iturrino J, Loscalzo J, Hall KT, and Silvester JA. Front Psychiatry. 2022. 13:842030.
    DOI: 10.3389/fpsyt.2022.842030. 
  100. Neocortical pyramidal neurons with axons emerging from dendrites are frequent in non-primates, but rare in monkey and human.
    Wahle P, Sobierajski E, Gasterstadt I, Lehmann N, Weber S, Lubke JHR, Engelhardt M, Distler C, and Meyer G. Elife. 2022. 11.
    DOI: 10.7554/eLife.76101.
  101. TRPM3-mediated dynamic mitochondrial activity in nerve growth factor-induced latent sensitization of chronic low back pain.
    Wang D, Gao Q, Schaefer I, Moerz H, Hoheisel U, Rohr K, Greffrath W, and Treede RD. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002642.
  102. Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis.
    Weber CE, Kramer J, Wittayer M, Gregori J, Randoll S, Weiler F, Heldmann S, Rossmanith C, Platten M, Gass A, and Eisele P. Eur Radiol. 2022. 32(3):2012-2022.
    DOI: 10.1007/s00330-021-08233-w.
  103. Long-term dynamics of multiple sclerosis iron rim lesions.
    Weber CE, Wittayer M, Kraemer M, Dabringhaus A, Bail K, Platten M, Schirmer L, Gass A, and Eisele P. Mult Scler Relat Disord. 2022. 57:103340.
    DOI: 10.1016/j.msard.2021.103340.
  104. MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesions.
    Wenzel N, Wittayer M, Weber CE, Schirmer L, Platten M, Gass A, and Eisele P. J Neurol. 2022. 269(8):4414-4420.
    DOI: 10.1007/s00415-022-11082-2.
  105. Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.
    Wick A, Sander A, Koch M, Bendszus M, Combs S, Haut T, Dormann A, Walter S, Pertz M, Merkle-Lock J, Selkrig N, Limprecht R, Baumann L, Kieser M, Sahm F, Schlegel U, Winkler F, Platten M, Wick W, and Kessler T. BMC Cancer. 2022. 22(1):645
    DOI: 10.1186/s12885-022-09720-z. 
  106. Hippocampal subfield involvement in patients with transient global amnesia.
    Wittayer M, Hoyer C, Rossmanith C, Platten M, Gass A, and Szabo K. J Neuroimaging. 2022. 32(2):264-267.
    DOI: 10.1111/jon.12973. 
  107. Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesions.
    Wittayer M, Weber CE, Kramer J, Platten M, Schirmer L, Gass A, and Eisele P. Magn Reson Imaging. 2022. 95:12-18.
    DOI: 10.1016/j.mri.2022.10.009. 
  108. Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability.
    Wittayer M, Weber CE, Platten M, Schirmer L, Gass A, and Eisele P. Mult Scler Relat Disord. 2022. 64:103967.
    DOI: 10.1016/j.msard.2022.103967. 
  109. Quadruple genetic variants in a sporadic ALS patient.
    Yilmaz R, Weishaupt K, Valkadinov I, Knehr A, Brenner D, and Weishaupt JH. Mol Genet Genomic Med. 2022. 10(7):e1953.
    DOI: 10.1002/mgg3.1953. 
  110. Systematic review and meta-analysis of studies in which burrowing behaviour was assessed in rodent models of disease-associated persistent pain.
    Zhang XY, Barakat A, Diaz-delCastillo M, Vollert J, Sena ES, Heegaard AM, Rice ASC, and Soliman N. Pain. 2022.
    DOI: 10.1097/j.pain.0000000000002632. 

PubMed publications by individual MCTN scientists